SUMIT PHARMACY · EDITORIAL

Pharmacy Knowledge. Industry Insights. Career Growth.

Explore pharmaceutical industry updates, regulatory developments, career opportunities, pharmacy education and practical insights for pharmacy students and professionals.

Pharmacy News & Updates Career & Education Regulatory Insights

EXPLORE TOPICS

All Types Career Guidance PCI Updates Pharma Jobs Pharma News Regulatory Affairs

CATEGORY ARCHIVE

Regulatory Affairs

Stay informed with the latest developments, useful guides and educational resources.

New articles and updates

Drug licence suspension proposal 2026 in India for substandard medicines and pharmaceutical quality failures

India Proposes Immediate Drug Licence Suspension 2026: New Rules for Substandard Medicines Explained

Drug licence suspension proposal 2026 is an important regulatory development for India’s pharmaceutical industry. The Ministry of Health and Family Welfare has proposed amendments to the Drugs Rules, 1945, that could allow immediate suspension…

By Sumit Singh · Nov 4, 2026

Read article

Explore the latest updates

Pharma News

CDSCO High-Risk Solvents 2026: Digital Tracking System, ONDLS and New NOC Requirements Explained

Last Updated: 3 November 2026 The CDSCO high-risk solvents 2026 regulatory update is an important development for India’s pharmaceutical manufacturing and…

Sumit Singh · Nov 3, 2026

Read article

Schedule H1 Drugs List 2026 showing current drugs, prescription rules and latest regulatory changes in India

Pharma News

Schedule H1 Drugs List 2026: Updated List, Rules, Prescription Requirements & Latest Changes

Last updated: 3 October 2026 If you are searching for the Schedule H1 drugs list 2026, there is an important point…

Sumit Singh · Oct 3, 2026

Read article

Featured illustration explaining the AI-generated prescriptions ban debate in India, covering e-pharmacy regulation, fake prescriptions, AIOCD protest, and CDSCO regulatory review.

Pharma News

AI-Generated Prescriptions Ban Debate in India (2026): The Complete Explainer

AI-generated prescriptions ban debate in India has become one of the biggest regulatory controversies in the Indian pharmaceutical sector in 2026.…

Sumit Singh · Jul 4, 2026

Read article

Pharmacy Knowledge. Industry Insights. Career Growth.

Regulatory Affairs

India Proposes Immediate Drug Licence Suspension 2026: New Rules for Substandard Medicines Explained

More Articles

CDSCO High-Risk Solvents 2026: Digital Tracking System, ONDLS and New NOC Requirements Explained

Schedule H1 Drugs List 2026: Updated List, Rules, Prescription Requirements & Latest Changes

AI-Generated Prescriptions Ban Debate in India (2026): The Complete Explainer

Need help with notes or downloads?